• SenesTech, a rodent fertility control product provider and the inventor of the only EPA-registered contraceptive for male and female rats, is offering a sustainable and proactive tool  in the fight against rodent pests
• With New York City reporting an estimated 3 million rats as one of the top five list of the most rat-infested cities in the U.S., it paints a grim picture of the situation at hand
• SenesTech’s Evolve(TM) soft bait products for both rats and mice has been scientifically proven to manage rodent infestations, allowing for a superior proactive approach to addressing the rodent problem
• The product was developed as a minimum risk product as defined by the EPA, posing little or no harm to the environment, people, or non-targeted animals such as birds of prey and cats

In 2023, it was estimated that New York City had roughly 3 million rats, an increase of almost 1 million over the last ten years. The situation has gotten so bad that the city has become almost synonymous with rat infestation problems.

This statistic paints an astonishing picture of the rodent problem in the U.S., and the need to better address it sustainably and effectively. SenesTech (NASDAQ: SNES), a rodent fertility control product provider and the inventor of the only EPA-registered contraceptive for male and female rats, promises an proactive tool that has been tried and tested and could potentially get rid of an entire rat population in only 12 to 18 months.

SenesTech’s flagship product line, Evolve(TM) soft bait for rats and mice has been shown to provide a reliable and safe method for managing infestations. Its high palatability and little to no risk to people, the environment, or non-target animals, makes it ideal for use in public or home environments. The active ingredient in the product, cottonseed oil, effectively interferes with the reproductive mechanisms in both male and female rats, thereby offering a more proactive approach to controlling the rodent population by targeting it at its source (https://ibn.fm/8QmvC).

SenesTech, through its offerings, promises a solution to a problem that so far has been impossible to solve. It offers a product that meets the necessary environmental and health requirements, particularly given the ongoing concerns about the use of poisons and their potential impact on non-targeted animals such as hawks, owls, and domestic cats.

The company has a powerful and much needed product in the market, and is building its share in a market that was valued at $5.6 billion in 2021 and was projected to grow at a CAGR of 7.1% between 2022 and 2032 (https://ibn.fm/UJ8pP).

For more information, visit the company’s website at www.SenesTech.com.

NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://ibn.fm/SNES

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Los Angeles, CA
www.MissionIR.com
310.299.1717 Office
[email protected]